Indication

Treatment of X-linked hypophosphataemia with radiographic evidence of bone disease in adults

Medicine details

Medicine name:
burosumab (Crysvita)
SMC ID:
SMC2927
Pharmaceutical company
Kyowa Kirin
BNF chapter
Endocrine system
Submission type
Ultra-orphan reassessment
Publication due date:
08 March 2027
SMC meeting date:
02 February 2027
Patient group submission deadline:
05 October 2026